168 related articles for article (PubMed ID: 37994665)
21. [Clinicopathological features of low-grade oncocytic renal tumor (CD117-negative, cytokeratin 7-positive): report of seven cases].
Xie B; Cheng LC; Yin GL; Liu BA; Hu ZL; Tong K
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):719-725. PubMed ID: 35922161
[No Abstract] [Full Text] [Related]
22. Intratumoral peripheral small papillary tufts: a diagnostic clue of renal tumors associated with Birt-Hogg-Dubé syndrome.
Kuroda N; Furuya M; Nagashima Y; Gotohda H; Moritani S; Kawakami F; Imamura Y; Bando Y; Takahashi M; Kanayama HO; Ota S; Michal M; Hes O; Nakatani Y
Ann Diagn Pathol; 2014 Jun; 18(3):171-6. PubMed ID: 24767893
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.
Lang M; Vocke CD; Merino MJ; Schmidt LS; Linehan WM
Mod Pathol; 2015 Nov; 28(11):1458-69. PubMed ID: 26428318
[TBL] [Abstract][Full Text] [Related]
24. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
25. Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma.
Schmidt LS
Curr Mol Med; 2004 Dec; 4(8):877-85. PubMed ID: 15579035
[TBL] [Abstract][Full Text] [Related]
26. Cytologic and histologic findings in multiple renal hybrid oncocytic tumors in a patient with Birt-Hogg-Dubé syndrome: a case report.
Adley BP; Schafernak KT; Yeldandi AV; Yang XJ; Nayar R
Acta Cytol; 2006; 50(5):584-8. PubMed ID: 17017453
[TBL] [Abstract][Full Text] [Related]
27. Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients.
Giunchi F; Fiorentino M; Vagnoni V; Capizzi E; Bertolo R; Porpiglia F; Vatrano S; Tamberi S; Schiavina R; Papotti M; Bollito E
Pathology; 2016 Jan; 48(1):41-6. PubMed ID: 27020208
[TBL] [Abstract][Full Text] [Related]
28. Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspects.
Kuroda N; Tanaka A; Ohe C; Mikami S; Nagashima Y; Sasaki T; Inoue K; Hes O; Michal M; Brunelli M; Martignoni G
Histol Histopathol; 2012 Nov; 27(11):1407-12. PubMed ID: 23018240
[TBL] [Abstract][Full Text] [Related]
29. [Birt-Hogg-Dubé syndrome: an update].
López V; Jordá E; Monteagudo C
Actas Dermosifiliogr; 2012 Apr; 103(3):198-206. PubMed ID: 21937013
[TBL] [Abstract][Full Text] [Related]
30. Emerging entities in renal cell neoplasia: thyroid-like follicular renal cell carcinoma and multifocal oncocytoma-like tumours associated with oncocytosis.
Eble JN; Delahunt B
Pathology; 2018 Jan; 50(1):24-36. PubMed ID: 29132724
[TBL] [Abstract][Full Text] [Related]
31. Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
Klomp JA; Petillo D; Niemi NM; Dykema KJ; Chen J; Yang XJ; Sääf A; Zickert P; Aly M; Bergerheim U; Nordenskjöld M; Gad S; Giraud S; Denoux Y; Yonneau L; Méjean A; Vasiliu V; Richard S; MacKeigan JP; Teh BT; Furge KA
BMC Med Genomics; 2010 Dec; 3():59. PubMed ID: 21162720
[TBL] [Abstract][Full Text] [Related]
32. Review of renal tumors associated with Birt-Hogg-Dubé syndrome with focus on clinical and pathobiological aspects.
Kuroda N; Furuya M; Nagashima Y; Gotohda H; Kawakami F; Moritani S; Ota S; Hora M; Michal M; Hes O; Nakatani Y
Pol J Pathol; 2014 Jun; 65(2):93-9. PubMed ID: 25119168
[TBL] [Abstract][Full Text] [Related]
33. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
34. Birt-Hogg-Dubé syndrome-associated renal cell carcinoma: Histopathological features and diagnostic conundrum.
Furuya M; Hasumi H; Yao M; Nagashima Y
Cancer Sci; 2020 Jan; 111(1):15-22. PubMed ID: 31777168
[TBL] [Abstract][Full Text] [Related]
35. Hybrid chromophobe renal cell neoplasm.
Mai KT; Dhamanaskar P; Belanger E; Stinson WA
Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
[TBL] [Abstract][Full Text] [Related]
36. Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations.
Adley BP; Smith ND; Nayar R; Yang XJ
Arch Pathol Lab Med; 2006 Dec; 130(12):1865-70. PubMed ID: 17149965
[TBL] [Abstract][Full Text] [Related]
37. [Birt-Hogg-Dubé syndrome : bilateral oncocytic kidney tumors in a patient].
Westermann DH; Rüdiger T; Lohe B; Frohneberg D
Urologe A; 2010 Dec; 49(12):1527-31. PubMed ID: 20949256
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
[TBL] [Abstract][Full Text] [Related]
39. Hybrid renal tumors in Birt-Hogg-Dubé syndrome.
Abbosh PH; Grubb RL; Cao D; Humphrey PA
J Urol; 2011 Dec; 186(6):2413-4. PubMed ID: 22019161
[No Abstract] [Full Text] [Related]
40. The genetics of renal oncocytosis: a possible model for neoplastic progression.
Al-Saleem T; Cairns P; Dulaimi EA; Feder M; Testa JR; Uzzo RG
Cancer Genet Cytogenet; 2004 Jul; 152(1):23-8. PubMed ID: 15193438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
